Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 20647 [2013-08032]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 66 / Friday, April 5, 2013 / Notices
Name: National Committee on Vital and
Health Statistics (NCVHS), Subcommittees
on Population Health and Privacy,
Confidentiality & Security.
Time and Date: April 30, 2013–May 2,
2013, 9:00 a.m.–5:00 p.m. EST.
Place: National Center for Health Statistics,
3311 Toledo Road, Hyattsville, MD 20782,
Tel: 1–301–458–4200.
Status: Open.
Purpose: The purpose of this meeting is to
provide an opportunity for the Population
Health and Privacy, Confidentiality and
Security Subcommittees to hear from data
providers, users, and experts in health data
on community uses of data to improve
health. NCVHS seeks to: (1) Advance its
understanding of access to and use of data by
communities to improve population health;
(2) refine its Stewardship Framework for the
Use of Community Health to support the
needs of various types of community
initiatives; and (3) better understand the role
of government in providing data, tools, and
resources to promote community driven
change.
The agenda is organized for attendees to
participate in breakout groups throughout the
day exploring such topics and themes as
‘‘How best to promote community
engagement and participation,’’ ‘‘How to
promote secure practices,’’ ‘‘How to achieve
information-enabled community-driven
change,’’ ‘‘What is the need for standardized
approaches for generating qualitative
information,’’ and ending with ‘‘What
analytic support can state and the Federal
government provide.’’ Participants will be
briefed on the results of a preliminary
environmental scan of programs supporting
local community data use as well as key
messages from the Committee’s report: the
Community as a Learning System: Using
Local Data to Improve Local Health. https://
www.ncvhs.hhs.gov/111213chip.pdf.
Contact Person for More Information:
Marjorie S. Greenberg, Executive Secretary,
NCVHS, National Center for Health Statistics,
Centers for Disease Control and Prevention,
3311 Toledo Road, Room 2402, Hyattsville,
Maryland 20782, telephone (301) 458–4245
or Maya Bernstein, lead staff for the Privacy,
Confidentiality & Security Subcommittee,
NCVHS, Hubert H. Humphrey Building,
Department of Health & Human Services, 200
Independence Ave SW., Washington, DC
20201, Telephone (202) 690–5896. Program
information as well as summaries of meetings
and a roster of committee members are
available on the NCVHS home page of the
HHS Web site: https://www.ncvhs.hhs.gov/,
where further information including an
agenda will be posted when available.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment Opportunity on
(301) 458–4EEO (4336) as soon as possible.
Dated: March 28, 2013.
James Scanlon,
Deputy Assistant Secretary for Planning and
Evaluation, Office of the Assistant Secretary
for Planning and Evaluation.
[FR Doc. 2013–08025 Filed 4–4–13; 8:45 am]
BILLING CODE 4151–05–P
VerDate Mar<15>2010
17:14 Apr 04, 2013
Jkt 229001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
Presidential Commission for
the Study of Bioethical Issues, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services.
ACTION: Notice of Meeting.
AGENCY:
The Presidential Commission
for the Study of Bioethical Issues will
conduct its thirteenth meeting on April
30, 2013. At this meeting, the
Commission will discuss the ethical
implications of incidental findings.
DATES: The meeting will take place
Tuesday, April 30, 2013.
ADDRESSES: The Hamilton Crowne Plaza
Hotel, 1001 14th St. NW., Washington,
DC 20005. Telephone (202) 682–0111.
FOR FURTHER INFORMATION CONTACT:
Hillary Wicai Viers, Communications
Director, Presidential Commission for
the Study of Bioethical Issues, 1425
New York Avenue NW, Suite C–100,
Washington, DC 20005. Telephone:
202–233–3960. Email:
Hillary.Viers@bioethics.gov. Additional
information may be obtained at
www.bioethics.gov.
SUMMARY:
Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
thirteenth meeting of the Presidential
Commission for the Study of Bioethical
Issues (the Bioethics Commission). The
meeting will be held from 9:00 a.m. to
approximately 5:15 p.m. on Tuesday,
April 30, 2013, in Washington, DC The
meeting will be open to the public with
attendance limited to space available.
The meeting will also be webcast at
www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the Bioethics
Commission. The Bioethics Commission
is an advisory panel of the nation’s
leaders in medicine, science, ethics,
religion, law, and engineering. The
Bioethics Commission advises the
President on bioethical issues arising
from advances in biomedicine and
related areas of science and technology.
The Bioethics Commission seeks to
identify and promote policies and
practices that ensure scientific research,
health care delivery, and technological
innovation are conducted in a socially
and ethically responsible manner.
The main agenda item for the
Bioethics Commission’s thirteenth
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00036
Fmt 4703
Sfmt 9990
20647
meeting is to discuss the ethical
implications of incidental findings.
The draft meeting agenda and other
information about the Bioethics
Commission, including information
about access to the webcast, will be
available at www.bioethics.gov.
The Bioethics Commission welcomes
input from anyone wishing to provide
public comment on any issue before it.
Respectful debate of opposing views
and active participation by citizens in
public exchange of ideas enhances
overall public understanding of the
issues at hand and conclusions reached
by the Bioethics Commission. The
Bioethics Commission is particularly
interested in receiving comments and
questions during the meeting that are
responsive to specific sessions. Written
comments will be accepted at the
registration desk and comment forms
will be provided to members of the
public in order to write down questions
and comments for the Bioethics
Commission as they arise. To
accommodate as many individuals as
possible, the time for each question or
comment may be limited. If the number
of individuals wishing to pose a
question or make a comment is greater
than can reasonably be accommodated
during the scheduled meeting, the
Bioethics Commission may make a
random selection.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify Esther Yoo by telephone
at (202) 233–3960, or email at
Esther.Yoo@bioethics.gov in advance of
the meeting. The Bioethics Commission
will make every effort to accommodate
persons who need special assistance.
Written comments will also be
accepted in advance of the meeting and
are especially welcome. Please address
written comments by email to
info@bioethics.gov, or by mail to the
following address: Public Commentary,
Presidential Commission for the Study
of Bioethical Issues, 1425 New York
Ave., NW., Suite C–100, Washington,
DC 20005. Comments will be publicly
available, including any personally
identifiable or confidential business
information that they contain. Trade
secrets should not be submitted.
Dated: March 21, 2013.
Lisa M. Lee,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2013–08032 Filed 4–4–13; 8:45 am]
BILLING CODE 4154–06–P
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 78, Number 66 (Friday, April 5, 2013)]
[Notices]
[Page 20647]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-08032]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Meeting of the Presidential Commission for the Study of
Bioethical Issues
AGENCY: Presidential Commission for the Study of Bioethical Issues,
Office of the Assistant Secretary for Health, Department of Health and
Human Services.
ACTION: Notice of Meeting.
-----------------------------------------------------------------------
SUMMARY: The Presidential Commission for the Study of Bioethical Issues
will conduct its thirteenth meeting on April 30, 2013. At this meeting,
the Commission will discuss the ethical implications of incidental
findings.
DATES: The meeting will take place Tuesday, April 30, 2013.
ADDRESSES: The Hamilton Crowne Plaza Hotel, 1001 14th St. NW.,
Washington, DC 20005. Telephone (202) 682-0111.
FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications
Director, Presidential Commission for the Study of Bioethical Issues,
1425 New York Avenue NW, Suite C-100, Washington, DC 20005. Telephone:
202-233-3960. Email: Hillary.Viers@bioethics.gov. Additional
information may be obtained at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given
of the thirteenth meeting of the Presidential Commission for the Study
of Bioethical Issues (the Bioethics Commission). The meeting will be
held from 9:00 a.m. to approximately 5:15 p.m. on Tuesday, April 30,
2013, in Washington, DC The meeting will be open to the public with
attendance limited to space available. The meeting will also be webcast
at www.bioethics.gov.
Under authority of Executive Order 13521, dated November 24, 2009,
the President established the Bioethics Commission. The Bioethics
Commission is an advisory panel of the nation's leaders in medicine,
science, ethics, religion, law, and engineering. The Bioethics
Commission advises the President on bioethical issues arising from
advances in biomedicine and related areas of science and technology.
The Bioethics Commission seeks to identify and promote policies and
practices that ensure scientific research, health care delivery, and
technological innovation are conducted in a socially and ethically
responsible manner.
The main agenda item for the Bioethics Commission's thirteenth
meeting is to discuss the ethical implications of incidental findings.
The draft meeting agenda and other information about the Bioethics
Commission, including information about access to the webcast, will be
available at www.bioethics.gov.
The Bioethics Commission welcomes input from anyone wishing to
provide public comment on any issue before it. Respectful debate of
opposing views and active participation by citizens in public exchange
of ideas enhances overall public understanding of the issues at hand
and conclusions reached by the Bioethics Commission. The Bioethics
Commission is particularly interested in receiving comments and
questions during the meeting that are responsive to specific sessions.
Written comments will be accepted at the registration desk and comment
forms will be provided to members of the public in order to write down
questions and comments for the Bioethics Commission as they arise. To
accommodate as many individuals as possible, the time for each question
or comment may be limited. If the number of individuals wishing to pose
a question or make a comment is greater than can reasonably be
accommodated during the scheduled meeting, the Bioethics Commission may
make a random selection.
Anyone planning to attend the meeting who needs special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting.
The Bioethics Commission will make every effort to accommodate persons
who need special assistance.
Written comments will also be accepted in advance of the meeting
and are especially welcome. Please address written comments by email to
info@bioethics.gov, or by mail to the following address: Public
Commentary, Presidential Commission for the Study of Bioethical Issues,
1425 New York Ave., NW., Suite C-100, Washington, DC 20005. Comments
will be publicly available, including any personally identifiable or
confidential business information that they contain. Trade secrets
should not be submitted.
Dated: March 21, 2013.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical
Issues.
[FR Doc. 2013-08032 Filed 4-4-13; 8:45 am]
BILLING CODE 4154-06-P
